Table 5.
Relapse-free survival | Overall survival | 1 LN versus >1 LN | |
---|---|---|---|
P | P | P | |
Im FOXP3 | 0.01 | 0.045 | 0.0003 |
Im PD-1 | 0.49 | 0.46 | 0.049 |
Im PD-L1 | 0.48 | 0.66 | 0.57 |
BRAF | 0.78 | 0.59 | 0.38 |
NRAS | 0.11 | 0.07 | 0.16 |
Relapse-free survival | Overall survival | 1 LN versus >1 LN | |
---|---|---|---|
P | P | P | |
Im FOXP3 | 0.01 | 0.045 | 0.0003 |
Im PD-1 | 0.49 | 0.46 | 0.049 |
Im PD-L1 | 0.48 | 0.66 | 0.57 |
BRAF | 0.78 | 0.59 | 0.38 |
NRAS | 0.11 | 0.07 | 0.16 |